IVD Medical Strengthens Balance Sheet With $19 Million Ethereum Buy

IVD Medical Commits $19M in ETH to Power Tokenization Platform and On-Chain Treasury Strategy

Hong Kong-listed IVD Medical Holdings has acquired $19 million (HK$149 million) worth of ether (ETH), signaling a strategic shift toward real-world asset (RWA) tokenization and active on-chain treasury management.

The investment will serve as a core component of ivd.xyz, IVD’s upcoming Ethereum-based platform designed to tokenize pharmaceutical IP and healthcare assets. The company plans to use ETH for functions such as ownership verification, automated revenue sharing, and governance compliance.

In a statement to CoinDesk, Chief Strategy Officer Gary Deng described Ethereum as “the most mature smart contract platform,” citing its high liquidity, institutional momentum, and recent regulatory clarity following the U.S. SEC’s approval of a spot ETH ETF.

The ETH will also back IVD’s planned IVDD stablecoin, intended to facilitate cross-border settlements within regulatory frameworks in Hong Kong and the U.S. Revenue generated on-chain will be automatically converted into ETH and added to the treasury.

Beyond holding ETH, IVD intends to deploy it into staking, re-staking, and derivatives strategies to enhance yields and reduce risk. This positions the company among a limited group of HKEX-listed firms with digital asset treasuries — most of which prioritize bitcoin.

Notable crypto treasuries in Hong Kong include Boyaa Interactive with over 3,100 BTC (valued above $300 million) and Meitu, which previously held a combined 31,000 ETH and 940 BTC. Other smaller holders include Yuxing InfoTech, Moon Inc., and Walnut Capital.

The move comes alongside a broader partnership with HashKey Group, the operator of the licensed HashKey crypto exchange in Hong Kong.